TCGA and HIPO subgroup analysis of patients that received radiotherapy implies the importance of c-MET and its downstream intracellular signaling for HNSCC progression during radiotherapy (Figure S1A). This evidence concerns the gene MET and head and neck squamous cell carcinoma.